starts

Single Dose of Trastuzumab Kick Starts Immune Response in Certain Breast Cancers
“Our study showed, for the first time, that the immune-cell–activating properties of trastuzumab are likely related to the subtypes of breast cancer,” Varadan said. “Knowing this can inform future trials studying the usefulness of adding immunotherapy ... [...]
1
Like
Save
University of Canberra starts company to develop new cancer treatment
Researchers hope the work will prove valuable beyond breast cancer, as the stem cells have also been detected in other aggressive cancers like ovarian and pancreatic. Clinical trials at Canberra Hospital are the treatment's next step. "So that we can ... [...]
1
Like
Save